DeCode Posts 35-Percent Rise in Q3 Revenue as Net Losses More Than Double | GenomeWeb
NEW YORK (GenomeWeb News) — DeCode Genetics today said third-quarter revenues decreased 35 percent as R&D spending rose 29 percent and loss increased 108 percent.
 
Total receipts for the three months ended Sept. 30 decreased to $8.6 million from $13.2 million year over year. Decode blamed the decline on lower alliance revenues in 2006, and because $11.8 million in revenue was deferred to future reporting periods.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.